Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-12 5:35 pm Unchanged | 2026-06-06 | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.000% | 0 (Unchanged) | Filing History |
| 2026-06-09 5:41 pm Purchase | 2026-06-06 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 93,845,778 23.900% | 402,991 (+0.43%) | Filing History |
| 2026-05-15 6:12 pm Purchase | 2026-03-31 | 13G | STANDARD BIOTOOLS INC. LAB | MAK Capital Fund LP | 26,172,626 6.700% | 6,205,061 (+31.08%) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.000% | 0 (Unchanged) | Filing History |
| 2026-01-07 5:42 pm Purchase | 2025-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | MAK Capital Fund LP | 19,967,565 5.190% | 19,967,565 (New Position) | Filing History |
| 2025-11-28 5:33 pm Purchase | 2025-11-25 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 93,442,787 24.200% | 12,578,472 (+15.56%) | Filing History |
| 2025-03-04 7:46 pm Purchase | 2025-02-28 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 80,864,315 21.600% | 7,098,241 (+9.62%) | Filing History |
| 2024-11-14 3:32 pm Sale | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 2,641,379 0.700% | -5,333,995 (-66.88%) | Filing History |
| 2024-11-12 6:01 pm Unchanged | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 17,292,092 4.650% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 22,452,115 6.000% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:59 pm Purchase | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 17,292,092 4.650% | 13,158,153 (+318.30%) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 22,452,115 6.000% | 20,434,905 (+1013.03%) | Filing History |
| 2024-10-21 4:26 pm Sale | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | Millennium Management LLC | 6,984,232 1.900% | -8,052,833 (-53.55%) | Filing History |
| 2024-08-14 8:54 pm Purchase | 2024-08-12 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 73,766,074 19.770% | 3,364,737 (+4.78%) | Filing History |
| 2024-06-03 5:20 pm Sale | 2024-05-30 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital, LLC | 70,401,337 18.910% | -5,936,401 (-7.78%) | Filing History |
| 2024-05-22 4:54 pm Purchase | 2024-05-17 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital, LLC | 76,337,738 20.370% | 1,802,072 (+2.42%) | Filing History |
| 2024-03-20 6:05 pm Purchase | 2024-03-18 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% | 29,544,805 (+101.51%) | Filing History |
| 2024-03-20 5:25 pm Purchase | 2024-03-18 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital, LLC | 74,535,666 19.250% | 9,238,070 (+14.15%) | Filing History |
| 2024-02-26 4:15 pm Purchase | 2024-02-16 | 13G | STANDARD BIOTOOLS INC. LAB | Millennium Management LLC | 15,037,065 5.200% | 15,037,065 (New Position) | Filing History |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,975,374 9.900% | 80,623 (+1.02%) | Filing History |